Natco Pharma's (NTPH) R&D; pipeline has been built with focus on (1) intricate chemistry and (2) many complex processes. Its 21 pending ANDAs are focused on high barrier to entry products (~50% in oncology and multiple sclerosis) that are difficult to manufacture, formulate or may face legal and re..